Question 1

What is LOPJLB’s current signal on CTNM?

Accepted Answer

LOPJLB’s latest quantitative signal on Contineum Therapeutics, Inc. (CTNM) is BUY in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is CTNM in?

Accepted Answer

Contineum Therapeutics, Inc. (CTNM) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Contineum Therapeutics, Inc. (CTNM) do?

Accepted Answer

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The companyâs lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary …

Question 4

Where is Contineum Therapeutics, Inc. based / listed?

Accepted Answer

Contineum Therapeutics, Inc. is based in US, listed on NASDAQ.

Contineum Therapeutics, Inc. (CTNM)

Key stats

Industry peers

Prediction markets

ANALYST & RATINGS

Company news